All News

The American Pharmacists Association (APhA) Foundation today announced 20 recipients of its 2017 Incentive Grants for Practitioner Innovation in Pharmaceutical Care.

A better understanding of the mechanisms of arthritis is needed to develop superior treatments.

Individuals with hepatitis C virus genotypes 1 -3 benefitted from treatment with MK-3682B

Viral loads were reduced in SIV-infected rhesus monkeys given an experimental vaccine in combination with an immune stimulant.

The FDA has approved Endoceutics' prasterone (Intrarosa), a once-daily vaginal insert for the treatment of women who experience moderate to severe pain during sexual intercourse as a result of menopause.

Flu vaccine market estimated to grow by $1 billion over the next decade.

A simple questionnaire and testing can help identify more patients with chronic obstructive pulmonary disease.

Top news of the day from across the health care landscape.

Scientists discovered an excipient that improved absorption of a prostate cancer drug 3-fold.

Human papilloma virus (HPV) causes about 31,000 cancers in women and men (and 4,000 deaths in women) annually.

Top news of the day from across the healthcare landscape.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Collaboration will examine potential opportunities for combining daratumumab and carfilzomib for the treatment of cancer.

Janssen has entered a clinical trial collaboration and supply agreement with Onyx to evaluate the efficacy and safety of Darzalex, the first-in-class CD38-directed immunotherapy daratumumab, in combination with a proteasome inhibitor carfilzomib and dexamethasone.

Buprenorphine is one of the most commonly prescribed medications to treat opioid addiction. In 2014, about 60-65% of Americans using medication-assisted treatment received buprenorphine. On July 6, 2016, the Department of Health and Human Services (HHS) announced that it will raise the limit on the number of patients that can receive the addiction medicine buprenorphine to 275 patients per qualified provider. This article describes potential monetary conflicts in proving buprenorphine, how increased access will affect pharmacists and what they can do to help patients in need of medication supported abstinence and substance abuse counseling.

Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients?

How green is your pharmacy? Think about how much you and your coworkers are reducing, reusing, and recycling in the pharmacy.

Combination immunotherapy more successful in treating advanced skin cancer.

A post-hoc analysis of a pair of phase 3 trials evaluating baricitinib in patients with rheumatoid arthritis (RA) showed significant improvement in patient-reported outcomes compared with placebo and adalimumab (Humira).

Testimony from women at different stages of life highlights the uncertainty of women’s healthcare without the Affordable Care Act.

Baricitinib is a once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of autoimmune and inflammatory diseases.

Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.

Two pilot studies are transplanting infected kidneys into patients and then treating them with curative hepatitis C medications.

Ibrance has received approval from the European Commission to treat metastatic breast cancer.

Investigators have discovered that 2 PARP proteins are involved with arterial diseases.

Facebook and Twitter posts targeted at medical residences could potentially reduce antibiotic resistance.

Top news of the day from across the healthcare landscape.

Low health literacy, financial instability, and lack of social support promote poor adherence.

Guidelines revise the FDA regulations governing 505(b)(2) applications and abbreviated new drug applications.

Top news of the day from across the health care landscape.